单中心儿童超声造影安全性与成本影响的回顾性分析
回顾分析2008年1月至2015年12月单中心305例儿童超声造影检查,无即刻不良反应,延迟不良反应2例(0.7%)为短暂性高血压和心动过速,均无症状且非基础疾病所致;与CT和MRI相比,每次超声造影可分别节省74美元和180美元。
要点
- 儿童超声造影检查中无即刻不良反应,延迟不良反应发生率为0.7%(2/305),均为短暂无症状。
- 超声造影每次检查成本94美元,低于CT的168美元和MRI的274美元,分别节省74美元和180美元。
- 超声造影主要用于肝脏病变定性(48.2%)和创伤评估(37.1%),可减少CT的电离辐射及MRI的钆对比剂、镇静和麻醉需求。
核心结论
- 儿童超声造影是一种安全且可能具有成本效益的影像学检查方法。
研究设计与样本
- 单中心回顾性分析,纳入2008年1月至2015年12月接受超声造影的305例儿童患者(男187例,女118例;年龄范围1个月至18岁),参考标准为影像报告记录的即刻反应及24小时内电子病历记录的延迟不良反应。
诊断标准与关键数值
- 延迟不良反应2/305(0.7%),为短暂性高血压和短暂性心动过速,均无症状且非基础疾病所致;无即刻不良反应。
临床应用与阅片要点
- 儿童超声造影可用于肝脏病变定性(147/305,48.2%)、创伤(113/305,37.1%)及肾脏、血管和腔内评估(45/305,14.8%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Because of concern over medical ionizing radiation exposure of children, contrast-enhanced ultrasound (CEUS) has generated interest as an inexpensive, ionizing radiation-free alternative to CT and MRI. CEUS has received approval for pediatric hepatic use but remains off-label for a range of other applications. The purposes of this study were to retrospectively analyze adverse incidents encountered in pediatric CEUS and to assess the financial benefits of reducing the number of CT and MRI examinations performed.
MATERIALS AND METHODS: All pediatric (patients 18 years and younger) CEUS examinations performed between January 2008 and December 2015 were reviewed. All immediate reactions deemed due to contrast examinations were documented in radiology reports. Electronic patient records were examined for adverse reactions within 24 hours not due to an underlying pathologic condition. With tariffs from the U.K. National Institute of Clinical Excellence analysis, CEUS utilization cost ($94) was compared with the CT ($168) and MRI ($274) costs of the conventional imaging pathway.
RESULTS: The records of 305 pediatric patients (187 boys, 118 girls; age range, 1 month-18 years) undergoing CEUS were reviewed. Most of the studies were for characterizing liver lesions (147/305 [48.2%]) and trauma (113/305 [37.1%]); the others were for renal, vascular, and intracavitary assessment (45/305 [14.8%]). No immediate adverse reactions occurred. Delayed adverse reactions occurred in two patients (2/305 [0.7%]). These reactions were transient hypertension and transient tachycardia. Neither was symptomatic, and both were deemed not due to the underlying disorder. The potential cost savings of CEUS were $74 per examination over CT and $180 over MRI.
CONCLUSION: Pediatric CEUS is a safe and potentially cost-effective imaging modality. Using it allows reduction in the ionizing radiation associated with CT and in the gadolinium contrast administration, sedation, and anesthesia sometimes required for MRI.
引用
- Yusuf GT, Sellars ME, Deganello A, et al. Retrospective Analysis of the Safety and Cost Implications of Pediatric Contrast-Enhanced Ultrasound at a Single Center. AJR Am J Roentgenol. 2016. PMID: 27959665. doi:10.2214/AJR.16.16700
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。